0 Bewertungen

ID

42142

Beschreibung

A Study of ARQ 197 in Combination With Erlotinib; ODM derived from: https://clinicaltrials.gov/show/NCT01251796

Link

https://clinicaltrials.gov/show/NCT01251796

Stichworte

  1. 29.05.16 29.05.16 -
  2. 13.04.21 13.04.21 - Dr. rer. medic Philipp Neuhaus
Hochgeladen am

13. April 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796

    Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796

    Inclusion Criteria
    Beschreibung

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    voluntary written informed consent for study participation must be obtained
    Beschreibung

    informed consent

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    a histologically or cytologically confirmed advanced/recurrent non-small-cell lung cancer
    Beschreibung

    non-small-cell lung cancer

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0007131
    history of ≥1 prior chemotherapy regimen (treatment with egfr tyrosine kinase inhibitors will be counted as one regimen)
    Beschreibung

    chemotherapy regimen

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0392920
    UMLS CUI [1,2]
    C1443775
    ecog ps of 0 or 1
    Beschreibung

    ecog

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    life expectancy of ≥3 months
    Beschreibung

    life expectancy

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0023671
    poor metabolizers as defined by cyp2c19 genotype
    Beschreibung

    CYP2 gene

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1332828
    Exclusion Criteria
    Beschreibung

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    anti-cancer chemotherapy, anti-cancer therapy with egfr-tki, hormone therapy, radiotherapy, immunotherapy, other investigational agents or anti-cancer antibody therapy within 28 days prior to arq 197 dose
    Beschreibung

    egfr-tki

    Datentyp

    boolean

    surgery for cancer within 28 days prior to arq 197 dose
    Beschreibung

    cancer surgery

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0920424
    active double cancer
    Beschreibung

    Multiple malignancy

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0346429
    known symptomatic brain metastases
    Beschreibung

    brain metastases

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0220650
    an intercurrent illness that is uncontrolled (e.g., infection, symptomatic congestive heart failure, unstable angina pectoris, symptomatic arrhythmia, interstitial pneumonia)
    Beschreibung

    intercurrent illness

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C3640977
    pregnant or lactating
    Beschreibung

    pregnant or lactating

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    subjects who wish to have a child and who would not agree to use contraceptive measures
    Beschreibung

    contraceptive measures

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0700589

    Ähnliche Modelle

    Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796

    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    C1512693 (UMLS CUI)
    informed consent
    Item
    voluntary written informed consent for study participation must be obtained
    boolean
    C0021430 (UMLS CUI [1])
    non-small-cell lung cancer
    Item
    a histologically or cytologically confirmed advanced/recurrent non-small-cell lung cancer
    boolean
    C0007131 (UMLS CUI [1])
    chemotherapy regimen
    Item
    history of ≥1 prior chemotherapy regimen (treatment with egfr tyrosine kinase inhibitors will be counted as one regimen)
    boolean
    C0392920 (UMLS CUI [1,1])
    C1443775 (UMLS CUI [1,2])
    ecog
    Item
    ecog ps of 0 or 1
    boolean
    C1520224 (UMLS CUI [1])
    life expectancy
    Item
    life expectancy of ≥3 months
    boolean
    C0023671 (UMLS CUI [1])
    CYP2 gene
    Item
    poor metabolizers as defined by cyp2c19 genotype
    boolean
    C1332828 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    egfr-tki
    Item
    anti-cancer chemotherapy, anti-cancer therapy with egfr-tki, hormone therapy, radiotherapy, immunotherapy, other investigational agents or anti-cancer antibody therapy within 28 days prior to arq 197 dose
    boolean
    cancer surgery
    Item
    surgery for cancer within 28 days prior to arq 197 dose
    boolean
    C0920424 (UMLS CUI [1])
    Multiple malignancy
    Item
    active double cancer
    boolean
    C0346429 (UMLS CUI [1])
    brain metastases
    Item
    known symptomatic brain metastases
    boolean
    C0220650 (UMLS CUI [1])
    intercurrent illness
    Item
    an intercurrent illness that is uncontrolled (e.g., infection, symptomatic congestive heart failure, unstable angina pectoris, symptomatic arrhythmia, interstitial pneumonia)
    boolean
    C3640977 (UMLS CUI [1])
    pregnant or lactating
    Item
    pregnant or lactating
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    contraceptive measures
    Item
    subjects who wish to have a child and who would not agree to use contraceptive measures
    boolean
    C0700589 (UMLS CUI [1])

    Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

    Mit * gekennzeichnete Felder sind notwendig.

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video